Keyphrases
Tumor Growth
100%
Angiotensin II Type 1 Receptor (AT1R)
100%
Radiation Effects
100%
Tumor Angiogenesis
100%
Vascular Endothelial Growth Factor Expression
100%
Angiotensin Type I Receptor
100%
Vascular Endothelial Growth Factor
60%
Combination Therapy
60%
Tumor Volume
40%
Cancer Treatment
20%
Tumor
20%
CD31
20%
C57BL
20%
Angiogenesis
20%
Antiangiogenic Agents
20%
Growth Rate
20%
Neovascularization
20%
Neutralizing Antibodies
20%
Reduced Expression
20%
Radiation Therapy
20%
Blood Vessels
20%
Tumor Progression
20%
Factor Level
20%
Radiation Dose
20%
Subcutaneous Tissue
20%
Real-time PCR Analysis
20%
Capillary Blood
20%
AT1R Antagonist
20%
LLC Cells
20%
AT1R Blockade
20%
Mean Vessel Density
20%
Medicine and Dentistry
Vasculotropin
100%
Neoplasm
100%
Tumor Progression
100%
Angiotensin 1 Receptor
100%
Angiogenesis
100%
Combination Therapy
50%
Cancer Therapy
16%
C57BL/6
16%
Neutralizing Antibody
16%
Real Time Polymerase Chain Reaction
16%
Subcutaneous Tissue
16%
Capillary (Blood Vessel)
16%
Angiogenesis Inhibitor
16%
Radiation Therapy
16%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Tumor Progression
100%
Angiogenesis
100%
Angiotensin II Receptor Type 1
100%
Tumor Volume
50%
CD31
25%
Neutralizing Antibody
25%
Real-Time Polymerase Chain Reaction
25%
C57BL 6 Mouse
25%
Neovascularization (Pathology)
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Neoplasm
100%
Vasculotropin
100%
Angiotensin 1 Receptor
100%
Combination Therapy
50%
Malignant Neoplasm
16%
C57BL 6 Mouse
16%
Angiogenesis Inhibitor
16%
Neovascularization (Pathology)
16%
Neutralizing Antibody
16%
Neuroscience
Vascular Endothelial Growth Factor
100%
Angiogenesis
100%
Angiotensin II Receptor Type 1
100%
Neutralizing Antibody
25%
Real-Time Polymerase Chain Reaction
25%
Angiogenesis Inhibitor
25%
Radiation Therapy
25%